Wesley J. Horton

Why Biotech Cos. Need Litigation Plans Before Bad News
Wesley Horton Published in Law360 Discussing Biotech Litigation Preparedness
As securities litigation continues to target biotechnology and life sciences companies at elevated levels,...
Read More
Proactive Strategies for Risk Management
How Biotech Companies Can Reduce Securities Litigation Risk Before a Clinical or Regulatory Setback
Biotech companies operate in a high-risk environment where innovation, regulation, investor expectations,...
Read More